Skip to main content

Table 2 Median cytokine levels among participants treated with high-dose and usual-dose ESA and unadjusted and adjusted odds of cytokine being above the median

From: Association between high-dose erythropoiesis-stimulating agents, inflammatory biomarkers, and soluble erythropoietin receptors

Variable

High-dose ESA

(≥1 mcg/kg/wk of

darbepoetin-α)

(n = 11)

Usual-Dose ESA

(< 1 mcg/kg/wk of

darbepoetin-α)

(n = 21)

Unadjusted Odds Ratio, *

(5-95% CI)

p-value

Adjusted Odds Ratio**,

(5-95% CI)

p-value

C-reactive protein (mg/l)

7.7 (4.8, 9.7)

2.4 (1.1, 9.2)

9.0 (1.5-53.4)

p = 0.01

16.0 (1.5-174.5)

p = 0.02

Interferon-γ (pg/mL)

12.4 (4.4, 18.3)

8.5 (3.8, 11.2)

4.3 (0.88-21.3)

p = 0.06

4.5 (0.5-37.2)

p = 0.2

Tumor necrosis factor-α (pg/mL)

68.7 (10.3, 202.4)

41.2 (15.8, 65.6)

1.32 (0.31-5.7)

p = 0.7

1.7 (0.2-14.4)

p = 0.6

Interleukin-1β (pg/mL)

1.0 (0.2, 2.0)

0.6 (0.3, 1.6)

1.32 (0.31-5.7)

p = 0.7

1.3 (0.1-11.4)

p = 0.8

Interleukin-2 (pg/mL)

18.2 (6.3, 33.1)

9.2 (4.5, 22.2)

4.3 (0.88-21.3)

p = 0.06

2.4 (0.3-18.8)

p = 0.4

Interleukin-6 (pg/mL)

21.3 (17.3, 26.3)

16.2 (13.5, 21.9)

4.3 (0.88-21.3)

p = 0.06

12.3 (1.1-143.2)

p = 0.04

Interleukin-8 (pg/mL)

63.5 (33.9, 63.5)

44.5 (34.3, 65.0)

1.32 (0.31-5.7)

p = 0.7

1.1 (0.2-8.3), p = 0.9

Interleukin-10 (pg/mL)

4.2 (1.3, 7.6)

1.5 (1.0, 3.3)

4.3 (0.88-21.3)

p = 0.06

4.3 (0.5-35.0)

p = 0.2

IL-12p40 (pg/mL)

32.8 (15.9, 37.0)

22.8 (16.1, 32.2)

2.3 (0.52-10.5)

p = 0.45

3.1 (0.4-23.2) p = 0.3

IL-12p70 (pg/mL)

4.4 (1.1, 8.1)

2.7 (1.6, 4.0)

4.3 (0.88-21.3)

p = 0.06

5.6 (0.7-47.2)

p = 0.1

  1. Median and 25th to 75th interquartile range
  2. *Odds ratio of cytokine being above the median among those in high vs usual dose ESA,
  3. **Adjusted for gender, hemoglobin and ferritin